CClinicalTrials.gg
CompletedNCT05878873Updated Jul 3, 2025Results posted

The Neural Mechanisms of Split-belt Treadmill Adaptation in People With Multiple Sclerosis

An interventional study of Split-belt Treadmill and Transcutaneous Electrical Nerve Stimulation (TENS) in Multiple Sclerosis, sponsored by Colorado State University. Completed at 1 site in United States. Open to participants aged 18 Years to 86 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-03.

Sponsored by Colorado State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
18 Years to 86 Years
Sex
All
01

Study summary

Majority of people with multiple sclerosis experience difficulty with balance and mobility, leading to an increased risk of falls. The goal of this clinical trial is to learn about brain activity during walking adaptation in people with multiple sclerosis. Also, this clinical trial will test a form of nerve stimulation to see if it can improve walking performance.

The main questions it aims to answer are:

  • What areas of the brain are the most active during walking adaptation?
  • Can nerve stimulation make walking adaptation more effective?

Participants will walk on a treadmill where each leg will go a different speed which will create walking adaptation. At the same time, brain scans will occur. There will be two sessions of walking adaptation, one with nerve stimulation, and one without nerve stimulation. Researchers will compare people with multiple sclerosis to healthy young adults to see if there are differences in brain activity.

Read the detailed description

Most people with MS (PwMS) experience significant gait asymmetries between the two legs leading to an increased risk of falls and musculoskeletal injury. The objective of this study is to investigate the neural mechanisms of gait adaptation and the effects of transcutaneous electrical nerve stimulation (TENS) on adaptability during split-belt treadmill training in PwMS. Our hypothesis is that TENS will strengthen sensorimotor integration via amplified afferent signaling, thereby enhancing adaptation, and further improving gait symmetry chronically. Functional near-infrared spectroscopy (fNIRS) will be used during a split-belt treadmill training paradigm to assess cortical activation during gait adaptation. Additionally, the effect of split-belt treadmill training coupled with TENS on gait adaptability in PwMS will be tested with experimental and a sham TENS split-belt treadmill sessions. Cortical activation and the effect of TENS on gait adaptability will be compared between young neurotypical adults and PwMS to assess differences that can be attributed to multiple sclerosis.

02

Conditions studied

  • Multiple Sclerosis

Browse trials for

Keywords

  • split-belt treadmill
  • adaptation
  • multiple sclerosis
  • functional near-infrared spectroscopy
  • cortical activation
  • gait asymmetry
  • locomotion
  • sensorimotor control
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's enrollment of 51 is close to the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Colorado State University is the lead sponsor of 112 studies on the registry; 19 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 86 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • A diagnosis of relapsing remitting multiple sclerosis OR a neurotypical adult (ages 18-86)
  • Not experiencing an active relapse
  • Able to stand and walk without an assistive device
  • Able to walk for three tenths of a mile without stopping to rest

Exclusion criteria

Exclusion Criteria:

  • Unable to walk for three tenths of a mile without assistance
  • Musculoskeletal injury in past 6 months
  • Lower extremity surgery in past 6 months
  • Unable to abstain from medications that impair balance
  • Currently pregnant
  • History of traumatic brain injury
  • History of vestibular disease
  • History of any other balance impairment unrelated to multiple sclerosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
51 participants (actual)

Study arms

  • Sham comparator
    Split-belt Treadmill Training without TENS

    During this arm, participants will perform split-belt treadmill training with sensory stimulation equipment outfitted but not active during all adaptation sessions.

    Behavioral: Split-belt Treadmill

  • Experimental
    Split-belt Treadmill Training with TENS

    During this arm, participants will perform split-belt treadmill training with active sensory stimulation occuring simultaneously during all adaptation sessions.

    Behavioral: Split-belt Treadmill · Device: Transcutaneous Electrical Nerve Stimulation (TENS)

Interventions

  • BehavioralSplit-belt Treadmill

    Split-belt treadmill training, where the speed of each leg is controlled independently has been shown to create gait adaptation where the coordination of each leg is altered, creating improved gait symmetry for people with walking impairments.

  • DeviceTranscutaneous Electrical Nerve Stimulation (TENS)

    TENS is a form of nerve stimulation that stimulates at a frequency below motor threshold, targeting activation of sensory receptors, such as muscle spindles. Electrodes that create this stimulation will be placed on the skin superficial to the muscle bellies of the tibialis anterior and rectus femoris.

06

What researchers measure

Primary outcomes

  1. Change in Cortical Activation

    Cortical activation is measured using functional near-infrared spectroscopy (fNIRS) during split-belt treadmill walking. Hemodynamic responses are modeled using a general linear model (GLM) applied to the oxyhemoglobin (HbO) signal. The model includes regressors for distinct phases of walking, with the primary contrast comparing early adaptation (strides 6-30 after split-belt onset) to a baseline walking period. The outcome is defined as the difference in this HbO beta weight contrast with TENS ON compared to TENS OFF. Activation is averaged across all fNIRS channels to provide a whole-brain estimate of cortical activity. A larger value indicates a greater increase in activation from baseline walking to early adaptation. This was measured on both training session 1 and training session 2 to account for the crossover design (i.e. participants are receiving TENS on different days).

    Time frame: Training session 1 (day 1), training session 2 (day 28)

  2. Change in Adaptation Savings

    Adaptation savings is defined as the difference in early adaptation performance between training session 1 (Day 1) and training session 2 (Day 28) during split-belt treadmill walking. Early adaptation is quantified using relative step length asymmetry (SLA), calculated from strides 6 to 30 following split-belt onset. SLA is computed from three-dimensional motion capture and force data as the difference between step lengths of the legs, normalized to total stride length: SLA = (Step Length\_fast - Step Length\_slow) / (Step Length\_fast + Step Length\_slow). This yields a unitless measure of asymmetry. The outcome measure is the difference in SLA between visits (training session 2 - training session 1). Larger values reflect faster adaptation at training session 2, consistent with retention of prior learning.

    Time frame: Training session 1 (day 1), training session 2 (day 28)

  3. Rate of Step Length Asymmetry Adaptation

    Step length asymmetry during early adaptation, representing the rate of adaptation. Early adaptation is quantified using relative step length asymmetry (SLA), calculated from strides 6 to 30 following split-belt onset. SLA is computed from three-dimensional motion capture and force data as the difference between step lengths of the legs, normalized to total stride length: SLA = (Step Length\_fast - Step Length\_slow) / (Step Length\_fast + Step Length\_slow). This yields a unitless measure of asymmetry. The outcome measure is the difference in early adaptation SLA during TENS ON compared to TENS OFF. Values closer to zero reflect faster adaptation.This analysis was performed only on data from each participant's first visit to avoid known effects of increased adaptation rate (learning) during subsequent exposures.

    Time frame: Training session 1 (day 1)

07

Results

Posted Jul 3, 2025

Participant flow

Participant flow — Overall Study
MilestoneSplit-belt Treadmill Training With TENS FirstSplit-belt Treadmill Training With TENS Second
Started2427
People with multiple sclerosis started:1516
People with multiple sclerosis completed:1316
Healthy controls started:911
Healthy controls completed:911
Completed2227
Not completed20
Withdrew: Lost to follow-up20

Outcome measures

PrimaryChange in Cortical Activation

Cortical activation is measured using functional near-infrared spectroscopy (fNIRS) during split-belt treadmill walking. Hemodynamic responses are modeled using a general linear model (GLM) applied to the oxyhemoglobin (HbO) signal. The model includes regressors for distinct phases of walking, with the primary contrast comparing early adaptation (strides 6-30 after split-belt onset) to a baseline walking period. The outcome is defined as the difference in this HbO beta weight contrast with TENS ON compared to TENS OFF. Activation is averaged across all fNIRS channels to provide a whole-brain estimate of cortical activity. A larger value indicates a greater increase in activation from baseline walking to early adaptation. This was measured on both training session 1 and training session 2 to account for the crossover design (i.e. participants are receiving TENS on different days).

Time frame:
Training session 1 (day 1), training session 2 (day 28)
Reported as:
Least squares mean · Unitless GLM beta weight (HbO)
Change in Cortical Activation
Unitless GLM beta weight (HbO)Split-belt Treadmill Training Without TENSSplit-belt Treadmill Training With TENS
People with Multiple Sclerosis0.054 ± 0.021-0.024 ± 0.021
Healthy Controls0.074 ± 0.025-0.016 ± 0.025
Statistical analysis
  • Split-belt Treadmill Training Without TENS vs Split-belt Treadmill Training With TENS · Mixed Models Analysis · p = 0.007 (This value was adjusted using false discovery rate.) · Mean difference (net): -0.078This estimate calculation is TENS ON - TENS OFF.
  • Split-belt Treadmill Training Without TENS vs Split-belt Treadmill Training With TENS · Mixed Models Analysis · p = 0.008 (This value was adjusted using false discovery rate.) · Mean difference (net): -0.089The estimate calculation is TENS ON - TENS OFF.
PrimaryChange in Adaptation Savings

Adaptation savings is defined as the difference in early adaptation performance between training session 1 (Day 1) and training session 2 (Day 28) during split-belt treadmill walking. Early adaptation is quantified using relative step length asymmetry (SLA), calculated from strides 6 to 30 following split-belt onset. SLA is computed from three-dimensional motion capture and force data as the difference between step lengths of the legs, normalized to total stride length: SLA = (Step Length\_fast - Step Length\_slow) / (Step Length\_fast + Step Length\_slow). This yields a unitless measure of asymmetry. The outcome measure is the difference in SLA between visits (training session 2 - training session 1). Larger values reflect faster adaptation at training session 2, consistent with retention of prior learning.

Time frame:
Training session 1 (day 1), training session 2 (day 28)
Reported as:
Least squares mean · Unitless Relative Step Length Asymmetry
Change in Adaptation Savings
Unitless Relative Step Length AsymmetrySplit-belt Treadmill Training With TENS FirstSplit-belt Treadmill Training With TENS Second
People with Multiple Sclerosis0.0032 ± 0.01030.0451 ± 0.0096
Healthy Controls0.0221 ± 0.01240.0278 ± 0.0112
Statistical analysis
  • Split-belt Treadmill Training With TENS First vs Split-belt Treadmill Training With TENS Second · Mixed Models Analysis · p = 0.014 (This value was adjusted using false discovery rate.) · Mean difference (net): 0.0420This estimate calculation is TENS ON - TENS OFF at Visit 2.
  • Split-belt Treadmill Training With TENS First vs Split-belt Treadmill Training With TENS Second · Mixed Models Analysis · p = 0.878 (This value was corrected with false discovery rate.) · Mean difference (net): -0.0058The estimate calculation is TENS ON - TENS OFF at Visit 2
PrimaryRate of Step Length Asymmetry Adaptation

Step length asymmetry during early adaptation, representing the rate of adaptation. Early adaptation is quantified using relative step length asymmetry (SLA), calculated from strides 6 to 30 following split-belt onset. SLA is computed from three-dimensional motion capture and force data as the difference between step lengths of the legs, normalized to total stride length: SLA = (Step Length\_fast - Step Length\_slow) / (Step Length\_fast + Step Length\_slow). This yields a unitless measure of asymmetry. The outcome measure is the difference in early adaptation SLA during TENS ON compared to TENS OFF. Values closer to zero reflect faster adaptation.This analysis was performed only on data from each participant's first visit to avoid known effects of increased adaptation rate (learning) during subsequent exposures.

Time frame:
Training session 1 (day 1)
Reported as:
Least squares mean · Unitless Relative Step Length Asymmetry
Rate of Step Length Asymmetry Adaptation
Unitless Relative Step Length AsymmetrySplit-belt Treadmill Training Without TENSSplit-belt Treadmill Training With TENS
People with Multiple Sclerosis-0.090 ± 0.012-0.088 ± 0.013
Healthy Controls-0.095 ± 0.014-0.103 ± 0.016
Statistical analysis
  • Split-belt Treadmill Training Without TENS vs Split-belt Treadmill Training With TENS · Mixed Models Analysis · p = 0.898 (This value was corrected using false discovery rate.) · Mean difference (final values): 0.002The estimate calculation is TENS ON - TENS OFF
  • Split-belt Treadmill Training Without TENS vs Split-belt Treadmill Training With TENS · Mixed Models Analysis · p = 0.698 (This value was corrected using false discovery rate.) · Mean difference (final values): -0.008The estimate calculation is TENS ON - TENS OFF

Adverse events

Collected over Adverse events were monitored during each study visit (visit 1 at day 1 and visit 2 at day 28) and between visits. Participants were not followed after study completion.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Split-belt Treadmill Training With TENS: People With Multiple Sclerosis0/29 (0%)0/29 (0%)0/29 (0%)
Split-belt Treadmill Training Without TENS: People With Multiple Sclerosis0/29 (0%)0/29 (0%)0/29 (0%)
Split-belt Treadmill Training With TENS: Healthy Controls0/20 (0%)0/20 (0%)0/20 (0%)
Split-belt Treadmill Training Without TENS: Healthy Controls0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

This population contained 28 people with multiple sclerosis and 20 healthy controls.

Age, Continuous
Age, Continuous(years)Split-belt Treadmill Training With TENS FirstSplit-belt Treadmill Training With TENS SecondTotal
People with Multiple Sclerosis55.5 ± 9.152.2 ± 11.653.7 ± 10.5
Healthy Controls57.3 ± 11.950.9 ± 15.553.8 ± 14.0
Sex: Female, Male
Sex: Female, Male(Participants)Split-belt Treadmill Training With TENS FirstSplit-belt Treadmill Training With TENS SecondTotal
People with Multiple Sclerosis — Female81119
People with Multiple Sclerosis — Male549
Healthy Controls — Female6612
Healthy Controls — Male358
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Split-belt Treadmill Training With TENS FirstSplit-belt Treadmill Training With TENS SecondTotal
People with Multiple Sclerosis — Hispanic or Latino101
People with Multiple Sclerosis — Not Hispanic or Latino121527
People with Multiple Sclerosis — Unknown or Not Reported000
Healthy Controls — Hispanic or Latino000
Healthy Controls — Not Hispanic or Latino91120
Healthy Controls — Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Split-belt Treadmill Training With TENS FirstSplit-belt Treadmill Training With TENS SecondTotal
People with Multiple Sclerosis — American Indian or Alaska Native000
People with Multiple Sclerosis — Asian000
People with Multiple Sclerosis — Native Hawaiian or Other Pacific Islander000
People with Multiple Sclerosis — Black or African American011
People with Multiple Sclerosis — White131427
People with Multiple Sclerosis — More than one race000
People with Multiple Sclerosis — Unknown or Not Reported000
Healthy Controls — American Indian or Alaska Native000
Healthy Controls — Asian000
Healthy Controls — Native Hawaiian or Other Pacific Islander000
Healthy Controls — Black or African American000
Healthy Controls — White91120
Healthy Controls — More than one race000
Healthy Controls — Unknown or Not Reported000
08

Study locations

1 site
  • The Sensorimotor Neuroimaging Laboratory
    Fort Collins, Colorado 80523, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Jul 25, 2023
  • Informed consent form · Oct 31, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — The data will not publicly available due to participant privacy.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05878873
Lead sponsor
Colorado State University
Collaborators
National Multiple Sclerosis Society
Responsible party
Brett Fling (Associate Professor, Colorado State University) — Principal investigator
First posted
May 26, 2023
Start date
Nov 28, 2023
Primary completion
Jun 30, 2024
Completion
Jun 30, 2024
Results posted
Jul 3, 2025
Last update
Jul 3, 2025

Study contacts

Brett W Fling, Ph.D.
principal investigator · Colorado State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion